重大疾病保険市場：保険タイプ、保険料体系、保険適用範囲別-世界予測2024-2030年

重大疾病保険市場規模は2023年に3,669億7,000万米ドルと推計され、2024年には3,987億5,000万米ドルに達し、CAGR 8.93％で2030年には6,680億1,000万米ドルに達すると予測されています。

重大疾病保険は、保険契約者が保険の対象となる明確な重大疾病と診断された場合に一時金を支払うよう設計されています。この保険商品は、治療費、日常生活費、収入減、がん、心臓発作、脳卒中、その他保険契約上重大とみなされる病気からの回復に必要なケアなど、従来の医療保険では通常カバーされない費用をカバーすることで、経済的な保護を提供することを目的としています。重大疾病保険は、重篤な病気による高額医療費のリスクに対する経済的保障を求める個人の間で主に利用されています。重大疾病保険は、社会人、高齢者、遺伝性の健康リスクを持つ人など、幅広いエンドユーザー層を対象としており、その有用性はさまざまな層に及んでいます。重大疾病保険市場の成長には、重大疾病保険とその利点に関する認知度の向上、世界の医療サービスと治療費の拡大、慢性疾患の有病率と老年人口の増加など、いくつかの要因が影響しています。しかし、重大疾病保険の保険料が高額であること、複雑な約款に伴う懸念、新興国での認知度の低さなど、市場には一定の限界があります。その一方で、カスタマイズされた保険商品で過疎市場に進出し、AIなどの先進テクノロジーを取り入れて保険パッケージをパーソナライズし、保険金請求を合理化し、ヘルスケアプロバイダーと協力して保険とヘルスケアのバンドルパッケージを提供することで、重大疾病保険市場に新たな道が開かれます。

保険タイプ費用対効果の高い保障を求め、重症患者向け団体保険への嗜好が高まる

雇用主やその他の組織は通常、従業員や組合員に団体保険を提供しています。これらの保険は、福利厚生パッケージの一部として重大疾病保障を提供するものであり、多くの場合、個人契約と比較して割安です。団体保険は様々な病気をカバーすることができ、診断時に一時金が支払われます。雇用主を通じて費用対効果の高い保障を求める個人に最適です。グループ保険は、雇用主が交渉した条件により、加入手続きが簡素化され、より幅広い保障オプションが得られる可能性があります。個人保険は、個人が保険会社から直接購入するものです。これらの保険は、個人特有の健康リスクや懸念事項に直接対応し、より個別化された保障を提供します。保険レベルや保険料はカスタマイズされ、契約者は条件を完全にコントロールできます。団体保険で提供される以上のカスタマイズされた保障をお探しの方に適しています。このオプションは、特定の健康上の弱点を持つ個人や、より包括的な補償を希望し、高い保険料を支払っても構わないという人にメリットがあります。団体保険と個人保険を比較した場合、主な違いはコスト、カスタマイズ性、利便性にあります。通常、団体契約は費用対効果が高く、加入が簡素化され、雇用主や組織によって事前に交渉された保障が提供されます。しかし、保障内容の調整や条件指定に関する柔軟性が劣る場合があります。一方、個人保険は高度なカスタマイズが可能であり、契約者は特定のニーズに合わせて補償内容を調整できます。このオプションは、より包括的な補償を提供する一方で、保険の個別化された性質のため、一般的に保険料が高くなります。

保険の適用範囲重大疾病保険による基本補償の利用拡大

重大疾病保険の基本的な保障には、通常、あらかじめ定義された重大な病気に対する保障が含まれています。がん、心筋梗塞、脳卒中などが多く、これらの病気と診断された場合に一時金が支払われます。この保障は、保険料が高くなる可能性のある包括的なプランを必要とせず、最も一般的な重大疾病に対するセーフティネットを求める個人に適しています。予算が限られている人や、家族に広範な健康問題の既往歴がほとんどない人に適しています。基本的な保障は、主に生命を脅かす最も一般的な3つの病気に対応しています。がんでは、一部の皮膚がんを除く様々な種類の悪性腫瘍の治療と関連費用をカバーし、心臓発作では、心臓発作と診断された後に一時金が支払われ、医療費や必要な生活習慣の調整を支援します。脳卒中では、リハビリ費用を含む脳卒中に起因する費用をカバーします。包括的な保障は、基本的な保障にとどまらず、より広範な疾病をカバーするもので、希少疾病を含むこともあります。多くの場合、早期発病や再発の保障など、その他の特典も含まれます。家族歴や個人的な健康上の懸念からリスクが高い人に最適です。包括的な保障は、より広範な病気や症状に対する保障があるため、安心感を求める人にも好まれます。包括的な保障は、基本的な保障にとどまらず、腎不全のように、一般的ではないが同様に重篤で、透析や腎移植が必要な慢性腎不全や末期腎不全など、重大な医療介入を必要とする病態をカバーし、大やけどでは、手術や長期リハビリテーションなど、重度のやけどに伴う治療費を保障し、臓器移植では、被保険者が心臓、肺、肝臓、膵臓、腎臓などの臓器移植を必要とする場合に一時金を支払う。

地域別インサイト

南北アメリカ、特に米国とカナダは、医療費の増加と重大疾病保険に対する意識の高まりにより、重大疾病保険の極めて重要な市場となっています。米国市場は、生活習慣病の罹患率が高いことと、保険業界が堅調であることが特徴であり、重大疾病保険の導入を促進しています。ラテンアメリカは追い上げを見せており、ブラジルやメキシコなどは経済状況の改善と保険の普及により成長を示しています。南北アメリカの規制環境は、商品の提供や市場開拓に大きな影響を与えます。欧州の重大疾病保険市場は先進国であり、英国、ドイツ、フランスでは高い普及率を示しています。重大疾病保険に対する高い認知度、強固なヘルスケアインフラ、政府の支援政策が市場を牽引しています。中東・アフリカの重大疾病保険市場はまだ始まったばかりだが、経済開拓、外国人人口の増加、ヘルスケア支出の増加により、大きな成長が見込まれています。しかし、認知度の低さ、保険に対する文化的障壁、医療インフラの未整備といった課題に直面している地域もあります。APACでは、中国の重大疾病保険市場が、政府の支援と中間層の増加によって急速に拡大しています。デジタル・ヘルス・サービスを含む製品提供のイノベーションに強い注目が集まっています。高齢化が進む日本では、重大疾病保険に対する需要が高まっており、日本の消費者は透明性の高い条件と終身補償の商品を優先しています。インドの重大疾病保険分野は、医療費の上昇と意識の高まりにより成長しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは重大疾病保険市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、重大疾病保険市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.重大疾病保険市場の市場規模および予測は？

2.重大疾病保険市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.重大疾病保険市場の技術動向と規制枠組みは？

4.重大疾病保険市場における主要ベンダーの市場シェアは？

5.重大疾病保険市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 重大疾病保険とその利点についての認識の高まり
    • 世界中でヘルスケアサービスと治療のコストが増大
    • 慢性疾患の増加と高齢者人口の増加
  • 抑制要因
    • 重大疾病保険の保険料が高い
  • 機会
    • AI技術を取り入れて保険パッケージをパーソナライズし、請求処理を効率化
    • ヘルスケア提供者との戦略的連携により、保険とヘルスケアをバンドルしたパッケージが提供されます。
  • 課題
    • 複雑な利用規約に関連する懸念
• 市場セグメンテーション分析
  • 保険の種類：重篤疾患に対する費用対効果の高い補償を求める団体保険の好感度が高まっている
  • ポリシーの適用範囲：基本的な適用範囲に対する重大疾病保険の使用が増加
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 重大疾病保険市場ポリシータイプ別

• グループポリシー
• 個別ポリシー

第7章 重大疾病保険市場プレミアムストラクチャー

• 半年ごと
• 月次
• 四半期ごと
• 年間

第8章 重大疾病保険市場保険適用範囲別

• 基本補償
• 包括的なカバレッジ

第9章 南北アメリカの重大疾病保険市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の重大疾病保険市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの重大疾病保険市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • AIAシンガポール、重篤疾患保護ギャップに対処するための新たな提案を発表
  • AXA、引受障壁を下げた新たな重大疾病保険を発表
  • ガーディアンが新しい重大疾病保険従業員福利厚生を発表
• 戦略分析と提言

第13章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CRITICAL ILLNESS INSURANCE MARKET RESEARCH PROCESS
• FIGURE 2. CRITICAL ILLNESS INSURANCE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CRITICAL ILLNESS INSURANCE MARKET DYNAMICS
• FIGURE 7. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. CRITICAL ILLNESS INSURANCE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. CRITICAL ILLNESS INSURANCE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CRITICAL ILLNESS INSURANCE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY GROUP POLICIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY GROUP POLICIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY INDIVIDUAL POLICIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY INDIVIDUAL POLICIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY HALF YEARLY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY HALF YEARLY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY MONTHLY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY MONTHLY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY QUARTERLY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY QUARTERLY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY YEARLY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY YEARLY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY HEART ATTACK, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY HEART ATTACK, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STROKE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STROKE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY MAJOR BURNS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY MAJOR BURNS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY ORGAN TRANSPLANT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY ORGAN TRANSPLANT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 57. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 58. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 65. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 66. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 67. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 68. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 71. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 72. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 73. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 74. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 75. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 76. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 77. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 78. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 79. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 80. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 81. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 82. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 83. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 84. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 85. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 86. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 87. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 88. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 89. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 90. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 91. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 92. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 93. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 94. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 95. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 96. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 97. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 98. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 99. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 100. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 101. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 102. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 103. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 104. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 105. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 106. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 107. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 108. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 110. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 112. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 114. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 116. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 118. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 120. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 121. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 122. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 123. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 124. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 125. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 126. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 127. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 128. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 129. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 130. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 131. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 132. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 133. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 134. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 135. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 136. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 137. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 138. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 139. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 140. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 141. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 142. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 143. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 144. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 145. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 146. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 147. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 148. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 149. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 150. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 151. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 152. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 153. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 154. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 155. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 156. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 157. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 158. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 159. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 160. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 161. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 162. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 163. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 164. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 165. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 166. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 167. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 168. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 169. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 170. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 171. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 172. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 173. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 174. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 175. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 176. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 177. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 178. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 179. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 180. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 181. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 182. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 183. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 184. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 185. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 186. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 187. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 188. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 189. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 190. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 191. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 192. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 193. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 194. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 195. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 196. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 197. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 198. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 199. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 200. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 201. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 202. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 204. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 205. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 206. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 207. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 208. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 209. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 210. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 211. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 212. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 213. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 214. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 215. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 216. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 217. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 218. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 219. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 220. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 221. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 222. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 223. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 224. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 225. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 226. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 227. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 228. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 229. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 230. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 231. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 232. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 233. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 234. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 235. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 236. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 237. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 238. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 239. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 240. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 253. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 254. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 255. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 256. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 257. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 258. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 259. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 260. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 261. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 262. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 263. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 264. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 265. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 266. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 267. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 268. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 269. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 270. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 271. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 272. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 273. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 274. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 275. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 276. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 277. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 278. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 279. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 280. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 281. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 282. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 283. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 284. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 285. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 286. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 287. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 288. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 289. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 290. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 291. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 292. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 293. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 294. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 295. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 296. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 297. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 298. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 299. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 300. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 301. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 302. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 303. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 304. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2024-2030 (USD MILLION)
• TABLE 305. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2023 (USD MILLION)
• TABLE 306. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2024-2030 (USD MILLION)
• TABLE 307. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2023 (USD MILLION)
• TABLE 308. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2024-2030 (USD MILLION)
• TABLE 309. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2023 (USD MILLION)
• TABLE 310. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2024-2030 (USD MILLION)
• TABLE 311. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2023 (USD MILLION)
• TABLE 312. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2024-2030 (USD MILLION)
• TABLE 313. ITALY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2023 (USD MILLION)
• TABLE 314. ITA

[194 Pages Report] The Critical Illness Insurance Market size was estimated at USD 366.97 billion in 2023 and expected to reach USD 398.75 billion in 2024, at a CAGR 8.93% to reach USD 668.01 billion by 2030.

Critical illness insurance is designed to offer policyholders a lump-sum payment if they are diagnosed with a distinct critical illness covered by the policy. This insurance product is intended to offer financial protection by covering costs not typically catered for by traditional health insurance, including treatment expenses, day-to-day bills, loss of income, and the care necessary during recovery from serious diseases such as cancer, heart attack, stroke, and other conditions deemed as critical by the policy. Critical illness insurance finds its application predominantly among individuals seeking financial security against the risk of high medical costs due to serious illnesses. It caters to a broad end-user base, including working professionals, elderly populations, and those with hereditary health risks, making its utility extensive across various demographics. Several factors influence the growth of the critical illness insurance market, including rising awareness about critical illness insurance and its benefits, expanding costs of healthcare services and treatments globally, and the growing prevalence of chronic illnesses and the increasing geriatric population. However, the market faces certain limitations, such as the high cost of premiums of critical illness insurance, concerns associated with complex terms and conditions, and limited awareness in emerging economies. On the other hand, expanding into underpenetrated markets with customized insurance products, incorporating advanced technologies, including AI, to personalize insurance packages and streamline claims processing, and collaborating with healthcare providers to offer bundled insurance and healthcare packages opens new avenues for the critical illness insurance market.

Policy Type: Increasing preference for group policies in critical illness for cost-effective coverage

Employers or other organizations typically provide group policies to their employees or members. These policies offer critical illness coverage as part of a benefits package, often at a reduced cost compared to individual policies. Group policies can cover a range of illnesses, providing a lump sum payment upon diagnosis. It is ideal for individuals seeking cost-effective coverage through their employer. Group policies cater to those preferring simplified enrollment processes and potentially broader coverage options due to negotiated terms by the employer. Individual policies are bought by individuals directly from the provider. These policies offer more personalized coverage, directly catering to the individual's specific health risks or concerns. Coverage levels and premiums are tailored, and the policyholder has complete control over the terms. It is suitable for those looking for customized coverage beyond what is offered in group policies. This option benefits individuals with specific health vulnerabilities or those who desire more comprehensive coverage and are willing to pay a higher premium. When comparing group and individual policies, the primary differences lie in cost, customization, and convenience. Group policies are typically more cost-effective, benefit from simplified enrollment, and offer coverage pre-negotiated by an employer or organization. However, they may offer less flexibility regarding coverage adjustments or condition specifications. On the other hand, individual policies provide a high degree of customization, allowing policyholders to tailor their coverage to specific needs. While this option offers more comprehensive coverage, it generally comes at a higher premium due to the personalized nature of the policy.

Policy Coverage: Growing usage of critical illness insurance for basic coverage

Basic coverage in critical illness insurance typically includes protection against a predefined list of critical illnesses. These often encompass cancer, heart attack, and stroke, offering a lump sum amount upon diagnosis of these conditions. This coverage is preferable for individuals seeking a safety net against the most common critical illnesses without the need for a comprehensive plan that may come with a higher premium. It is suitable for those with limited budgets or minimal familial history of broader health issues. Basic coverage primarily addresses the three most common and life-threatening illnesses; in cancer, it covers treatments and associated costs for various types of malignant tumors, excluding some skin cancers; in heart attack, it provides a lump sum payment post-diagnosis of a heart attack, aiding in medical expenses and any lifestyle adjustments needed; and in strokes, it offers coverage for expenses arising from a stroke, including rehabilitation costs. Comprehensive coverage extends beyond the basics, covering a wider array of illnesses, sometimes including rare diseases. It often includes additional benefits such as early-stage illnesses and recurrent conditions coverage. It is ideal for those with a higher risk profile due to family history or personal health concerns. Comprehensive coverage is also preferred by individuals seeking peace of mind, knowing they have protection against a broader spectrum of illnesses and conditions. Comprehensive coverage extends beyond the Basic, covering less common but equally severe conditions that require significant medical intervention, such as kidney failure, to cover chronic or end-stage kidney failure needing dialysis or a kidney transplant; in major burns, it provides coverage for treatment costs associated with severe burn injuries, including surgeries and long-term rehabilitation; and in organ transplant, it offers a lump sum payment if the insured requires an organ transplant, including heart, lung, liver, pancreas, or kidney.

Regional Insights

The Americas, particularly the United States and Canada, are pivotal markets for critical illness insurance owing to the increasing healthcare costs and a growing awareness of critical illness insurance. The U.S. market is characterized by a high prevalence of lifestyle diseases and a robust insurance industry, facilitating the adoption of critical illness policies. Latin America is catching up, with countries such as Brazil and Mexico witnessing growth due to improving economic conditions and insurance penetration. Regulatory environments across the Americas significantly influence product offerings and market development. Europe's critical illness insurance market is developed, with high penetration rates in the UK, Germany, and France. The market is driven by a high level of awareness about critical illness insurance, a strong healthcare infrastructure, and supportive government policies. The critical illness insurance market in the Middle East and Africa is nascent but is expected to grow significantly due to economic development, an increasing expatriate population, and rising healthcare expenditure. However, the market faces challenges such as low awareness levels, cultural barriers to insurance, and underdeveloped healthcare infrastructure in certain parts. In APAC, China's critical illness insurance market is expanding rapidly, driven by governmental support and a growing middle class. There's a strong focus on innovation in product offerings, including digital health services. Japan's aging population has increased demand for critical illness insurance, and Japanese consumers prioritize products with transparent terms and lifetime coverage. India's critical illness insurance sector is growing due to rising healthcare costs and increased awareness.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Critical Illness Insurance Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Critical Illness Insurance Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Critical Illness Insurance Market, highlighting leading vendors and their innovative profiles. These include Aegon Life Insurance Company Limited, Aflac Group, AIA Group Limited, American International Group, AmMetLife Insurance Berhad, Aviva Group, AWP Health & Life S.A, Bharti AXA Life Insurance Company Limited, China Life Insurance (Overseas) Company Limited, China Pacific Life Insurance (H.K.) Company Limited, Chubb Group of Insurance Companies, Future Generali India Insurance Company Limited, HDFC ERGO General Insurance Company Limited, ICICI Prudential Life Insurance Co. Ltd., Legal & General Group PLC, Liberty General Insurance Limited, Manulife Financial, Max Life Insurance Company Limited, MetLife, Inc., New York Life Insurance Company, Niva Bupa Health Insurance Company Limited, Ping An Insurance (Group) Company of China, Ltd., Plum Benefits Insurance Brokers Pvt Ltd., Policybazaar Insurance Brokers Private Limited, Prudential Financial, Inc., Royal London Group, Sun Life Inc., The Cigna Group Corporation, The Hospitals Contribution Fund of Australia Ltd., The Manufacturers Life Insurance Company, Tokio Marine Insurance Group, UnitedHealth Group, and Zurich Group.

Market Segmentation & Coverage

This research report categorizes the Critical Illness Insurance Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Policy Type
  • Group Policies
  • Individual Policies

• Premium Structure
  • Half Yearly
  • Monthly
  • Quarterly
  • Yearly

• Policy Coverage
  • Basic Coverage
    • Cancer
    • Heart Attack
    • Stroke

• Comprehensive Coverage
  • Kidney Failure
  • Major Burns
  • Organ Transplant
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Critical Illness Insurance Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Critical Illness Insurance Market?

3. What are the technology trends and regulatory frameworks in the Critical Illness Insurance Market?

4. What is the market share of the leading vendors in the Critical Illness Insurance Market?

5. Which modes and strategic moves are suitable for entering the Critical Illness Insurance Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness about critical illness insurance and its benefits
    • 5.1.1.2. Expanding costs of healthcare services and treatments globally
    • 5.1.1.3. Growing prevalence of chronic illnesses and the increasing geriatric population
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of premiums of critical illness insurance
  • 5.1.3. Opportunities
    • 5.1.3.1. Incorporating AI technologies to personalize insurance packages and streamline claims processing
    • 5.1.3.2. Strategic collaboration with healthcare providers offers bundled insurance and healthcare packages.
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with complex terms and conditions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Policy Type: Increasing preference for group policies in critical illness for cost-effective coverage
  • 5.2.2. Policy Coverage: Growing usage of critical illness insurance for basic coverage
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Critical Illness Insurance Market, by Policy Type

• 6.1. Introduction
• 6.2. Group Policies
• 6.3. Individual Policies

7. Critical Illness Insurance Market, by Premium Structure

• 7.1. Introduction
• 7.2. Half Yearly
• 7.3. Monthly
• 7.4. Quarterly
• 7.5. Yearly

8. Critical Illness Insurance Market, by Policy Coverage

• 8.1. Introduction
• 8.2. Basic Coverage
• 8.3. Comprehensive Coverage

9. Americas Critical Illness Insurance Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Critical Illness Insurance Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Critical Illness Insurance Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. AIA Singapore launches new proposition to address the critical illness protection gap
  • 12.3.2. AXA unveils new critical illness plan with lower underwriting barriers
  • 12.3.3. Guardian Announces New Critical Illness Insurance Employee Benefit
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio